First-line csDMARD monotherapy drug retention in psoriatic arthritis: methotrexate outperforms sulfasalazine

OBJECTIVES: Conventional synthetic DMARDs (csDMARDs) are the first-line treatment for PsA, but there is conflicting data regarding their efficacy and scarce reports describing the duration of use (drug retention) of csDMARD in this population. Their position in treatment recommendations is a matter...

Descripción completa

Detalles Bibliográficos
Autores principales: Jacobs, Marleen E, Pouw, Juliëtte N, Welsing, Paco, Radstake, Timothy R D J, Leijten, Emmerik F A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850548/
https://www.ncbi.nlm.nih.gov/pubmed/32797218
http://dx.doi.org/10.1093/rheumatology/keaa399

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850548/
https://www.ncbi.nlm.nih.gov/pubmed/32797218
http://dx.doi.org/10.1093/rheumatology/keaa399

Ejemplares similares